相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article
Medicine, General & Internal
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
Patrick C. DeMartino et al.
Summary: This study aims to estimate the number of eligible cancer patients for newly approved drug-indication pairs and project the potential spending and use in the US. The findings suggest that if all eligible patients use the 2018 FDA-approved oncology drugs, there would be a $39.5 billion increase in cancer drug spending, while using the drugs in fewer than 20% of eligible patients is consistent with industry forecasts for drug spending.
JAMA INTERNAL MEDICINE (2021)
Article
Multidisciplinary Sciences
Contribution of NIH funding to new drug approvals 2010-2016
Ekaterina Galkina Cleary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)